# Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

> **NCT02266849** · PHASE3 · TERMINATED · sponsor: **Odense University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Rectal Cancer
- Ulcerative Colitis
- Short Bowel Syndrome

## Interventions

- **DRUG:** Loperamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02266849
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Insuficcient recruiting
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266849, "Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02266849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*